Researcher

The petition was approved based on the satisfaction of at least three EB-1A criteria, including 16 peer-reviewed journal articles and 4 book chapters. The petitioner demonstrated significant influence through 456 citations and the completion of at least 10 peer reviews for scholarly journals. The evidence established that the petitioner's AI-powered computational methods are actively used by leading research institutions worldwide.

The petitioner submitted evidence of 18 peer-reviewed scientific articles with 1,115 citations, demonstrating significant field impact. He also proved his expertise by completing at least 25 peer reviews for leading journals. Furthermore, his work received major funding from the National Institutes of Health (NIH) and the National Natural Science Foundation of China.

The petition was approved based on a distinguished record of 63 peer-reviewed journal articles and 1,099 citations on Google Scholar. The petitioner also demonstrated expertise through 75 completed peer reviews for leading journals. Additionally, the case was supported by prestigious funding from the NIH, the Cystic Fibrosis Foundation, and the Agricultural Research Service.

The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.